122805-79-2

Basic information

• Product Name: ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE
• Synonyms: ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE
• CAS NO: 122805-79-2
• Molecular Formula: C8H9NO3S
• Molecular Weight: 199.23
• Mol File: 122805-79-2.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE(122805-79-2)
• EPA Substance Registry System: ETHOXY-N-(2-FORMYL(3-THIENYL))FORMAMIDE(122805-79-2)

Safety Data

• Hazardous Substances Data: 122805-79-2(Hazardous Substances Data)

Upstream product

• 118235-88-4 methyl 3-(ethoxycarbonylamino)-thiophene-2-carboxylate 
• 541-41-3 chloroformic acid ethyl ester 
• 64761-70-2 thieno<3,2-c>isothiazole 
• 126033-45-2 (2-hydroxymethyl-thiophen-3-yl)-carbamic acid ethyl ester 
• 22288-78-4 Methyl 3-aminothiophene-2-carboxylate 

Relevant articles and documents

Synthesis of the fused heterobicycles 5-pyridin-2-yl-thieno[3,2-b]pyridine, 6-pyridin-2-yl-thieno[2,3-b]pyridine and 6-pyridin-2-yl-thieno[3,2-c]pyridine

Three new pyridyl thienopyridines, 5-pyridin-2-yl-thieno[3,2-b]pyridine, 6-pyridin-2-yl-thieno[2,3-b]pyridine and 6-pyridin-2-yl-thieno[3,2-c]pyridine, have been synthesized, each through a different synthetic sequence. Overall yields ranged from 8% to 32%. Georg Thieme Verlag Stuttgart.

Modified aminoacids, pharmaceuticals containing these compounds and method for their production

The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4and R11are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.

Modified amino acids, pharmaceuticals containing these compounds and method for their production

The present invention relates to modified amino acids of general formula wherein A, Z, X, n, m, R, R2, R3, R4 and R11 are defined as in claims 1 to 5, their tautomers, their diastereomers, their enantiomers, the mixtures thereof and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, pharmaceutical compositions containing these compounds, the use thereof and processes for preparing them as well as their use for the production and purification of antibodies and as labelled compounds in RIA- and ELISA assays and as diagnostic or analytical aids in neurotransmitter research.